Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1580998rdf:typepubmed:Citationlld:pubmed
pubmed-article:1580998lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1580998lifeskim:mentionsumls-concept:C0242275lld:lifeskim
pubmed-article:1580998lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:1580998lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:1580998lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:1580998lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:1580998pubmed:issue1lld:pubmed
pubmed-article:1580998pubmed:dateCreated1992-6-18lld:pubmed
pubmed-article:1580998pubmed:abstractTextAn interferon gamma (IFN-gamma) mutant gene harboring an additional epidermal growth factor (EGF) sequence at its 3' terminal was constructed and highly expressed in E. coli by using pBV220 as a vector. The new fusion protein-IFN-gamma-EGF possesses not only high antiviral activity, but also high antiproliferative effect as demonstrated by 3H-TdR incorporation method using CN II cells which are rich in EGF receptors.lld:pubmed
pubmed-article:1580998pubmed:languageenglld:pubmed
pubmed-article:1580998pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580998pubmed:citationSubsetIMlld:pubmed
pubmed-article:1580998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580998pubmed:statusMEDLINElld:pubmed
pubmed-article:1580998pubmed:monthJanlld:pubmed
pubmed-article:1580998pubmed:issn1001-652Xlld:pubmed
pubmed-article:1580998pubmed:authorpubmed-author:LiY YYYlld:pubmed
pubmed-article:1580998pubmed:authorpubmed-author:HouY DYDlld:pubmed
pubmed-article:1580998pubmed:authorpubmed-author:WangX MXMlld:pubmed
pubmed-article:1580998pubmed:authorpubmed-author:JinQQlld:pubmed
pubmed-article:1580998pubmed:authorpubmed-author:ZhangZ QZQlld:pubmed
pubmed-article:1580998pubmed:issnTypePrintlld:pubmed
pubmed-article:1580998pubmed:volume35lld:pubmed
pubmed-article:1580998pubmed:ownerNLMlld:pubmed
pubmed-article:1580998pubmed:authorsCompleteYlld:pubmed
pubmed-article:1580998pubmed:pagination84-91lld:pubmed
pubmed-article:1580998pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:meshHeadingpubmed-meshheading:1580998-...lld:pubmed
pubmed-article:1580998pubmed:year1992lld:pubmed
pubmed-article:1580998pubmed:articleTitleA new human interferon-gamma mutant harboring EGF receptor-interfering sequence possesses high antiproliferative activity.lld:pubmed
pubmed-article:1580998pubmed:affiliationNational Laboratory of Molecular Virology and Genetic Engineering, Chinese Academy of Preventive Medicine, Beijing.lld:pubmed
pubmed-article:1580998pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1580998pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1580998lld:pubmed